Skip to content

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06657781
Acronym
PLAQSEPSIS
Enrollment
171
Registered
2024-10-24
Start date
2022-11-30
Completion date
2026-11-30
Last updated
2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Sepsis

Keywords

Sepsis, platelet, NLRP3, BTK, IL-1β

Brief summary

: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Leucine Rich repeat containing Protein 3 (NLRP3) inflammasome in platelets between five groups of patients suffering from bacterial and/or viral sepsis, with different severity levels according to Sequential Organ Failure Assessment (SOFA) score to precise the platelets' implication in this cytokine storm.

Detailed description

Patients with bacterial or vial sepsis have been shown to exhibit very high levels of pro-inflammatory cytokines (IL1, IL6, IFN, IP10 and MCP1) that may activate the T-helper-1 lymphocytic response (Th1). These cytokines can be produced by several cell types, including blood platelets. IL1 is an important pro-inflammatory cytokine whose expression is increased in various pro-inflammatory contexts, including dengue infection. It induces an increase in endothelial permeability and a pro-thrombotic state, as described in patients infected with COVID-19. It is synthesized as a protein precursor that is cleaved by the NLRP3 (Nucleotide-binding domain Leucine repeat Rich containing Protein 3). Close associations between the deregulation of inflammasome activity and hereditary or acquired diseases suggest an important role of NLRP3 inflammasome in regulating immune responses. The activation of the NLRP3 inflammasome increases caspase 1 activity and induces the production of bioactive IL1 as well as other pro-inflammatory cytokines such as IL18. The major role of NLRP3 platelet inflammasome in the cytokine storm has been highlighted in the case of Dengue virus infection. We hypothesize that blood platelets may play an important role in the inflammatory response observed during sepsis through the activation of NLRP3 inflammasome, particularly during its exacerbation. * Five groups of patients will be constituted: patients with leptospirosis, patients with bacterial infections including in-hospital-acquired-infections, patients with viral infection, patients non infected (control group), patients with viral infection SARS-COv2 +. * Only one blood collection will be realized

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de la Guadeloupe
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* For all groups: patients older than 18 years at inclusion and acceptation of participation by the patient, his relative or his legal representative (depending on the situation) * For groups 1, 2, 3 and 5: Patient with a confirmed sepsis (microbiological confirmation) * For group 4 : Patient non infected

Exclusion criteria

* Refusal of participation by the patient, his relative or his legal representative (depending on the situation) * Patients subject to a safeguard measure of justice * Patients younger than 18 years at inclusion

Design outcomes

Primary

MeasureTime frameDescription
Nucleotide-binding domain Leucine Rich repeat containing Protein 3 activationBaselineThe primary outcome will be the evaluation of platelets' NLRP3 activation in septic patients according to the severity of the disease

Secondary

MeasureTime frameDescription
Confocal MicroscopyBaselineWe aim to confirm the colocalization of NRLP3/ASC in inflammasome activation by confocal microscopy

Countries

Guadeloupe

Contacts

Primary ContactFrédéric MARTINO, Doctor
frederic.martino@chu-guadeloupe.fr+590 590 89 10 10

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026